Disclosures for "6-month Real-world Effectiveness of Fremanezumab in Patients with Migraine who Switched from Another mAb Targeting the CGRP Pathway (Subgroup Analysis from FINESSE)"
-
Andreas Straube has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TEVA. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Andreas Straube has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan. Andreas Straube has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. The institution of Andreas Straube has received research support from German research Counci (BMBF).
-
Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for TEVA. Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for Lilly. Gregor Broessner has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Gregor Broessner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Gregor Broessner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly.
-
Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Weber & Weber, Lundbeck, and Perfood. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan Pharma, Lilly, Novartis Pharma, Hormosan Pharma, Sanofi-Aventis, Perfood, and TEVA. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan Pharma, Lilly, Novartis Pharma, Hormosan Pharma, Grünenthal, Sanofi-Aventis, and TEVA. Dr. Gaul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Journal of Headache and Pain, Acta Neurologica Scandinavia. Dr. Gaul has received publishing royalties from a publication relating to health care. Dr. Gaul has received personal compensation in the range of $0-$499 for serving as a Honorary secretary with German Migraine and Headache Society.
-
Dr. Hamann has received personal compensation for serving as an employee of Teva GmbH.
-
Dr. Hipp has received personal compensation for serving as an employee of Teva.
-
Dr. Kraya has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA, Novartis, Lilly. Dr. Kraya has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA, Novartis, Lilly, Hormosan, Abbvie.
-
Dr. Neeb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Neeb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Neeb has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Neeb has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Neeb has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Neeb has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Neeb has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Neeb has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Neeb has received research support from Teva. The institution of Dr. Neeb has received research support from Eli Lilly.